reference/30420737

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/30420737

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
issn	1743-422X
issueIdentifier	1
pageRange	11-
publicationName	Virology Journal
startingPage	11
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_316aa1d8e41719a0fe8ddba5c6bd5c92 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_487baf6554eb36bb22c6138d90a7c50f http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_70abf1ffb7b93a873efff855532f08ab
bibliographicCitation	Wu J, Huang P, Fan H, Tian T, Xia X, Fu Z, Wang Y, Ye X, Yue M, Zhang Y. Effectiveness of ombitasvir/paritaprevir/ritonavir, dasabuvir for HCV in HIV/HCV coinfected subjects: a comprehensive analysis. Virology Journal. 2019 Jan 17;16(1):11. doi: 10.1186/s12985-018-1114-4.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0c4c4c3df1be3d82352d3ce192890e81 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1da3841df0d1b08d6a2fb1b20dfbf528 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7e86c7848c70297e7c3ff4cd67a3c3a1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_054726be032126b977d3081aa99cc03c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a494c07ab750b7ac954dd15dfb13d7b7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a5cad832f10269764b9428f39267bfad http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-5043-0015 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0bed0bfc038d105c632b616d06eddac1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e86012ae9cc5c9b6101e2c8578afb7be http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-7677-0832 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_57a557ce051e9c4b3f5ea48796bba37a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9137fe389d3788dfc8786b5f58f9a09a
date	2019-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1186/s12985-018-1114-4 https://pubmed.ncbi.nlm.nih.gov/PMC6337763 https://pubmed.ncbi.nlm.nih.gov/30654809
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/32145 https://portal.issn.org/resource/ISSN/1743-422X
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/ https://scigraph.springernature.com/
title	Effectiveness of ombitasvir/paritaprevir/ritonavir, dasabuvir for HCV in HIV/HCV coinfected subjects: a comprehensive analysis
discusses	http://id.nlm.nih.gov/mesh/M0594121 http://id.nlm.nih.gov/mesh/M0594216 http://id.nlm.nih.gov/mesh/M0028918 http://id.nlm.nih.gov/mesh/M0001518 http://id.nlm.nih.gov/mesh/M0023197 http://id.nlm.nih.gov/mesh/M0022302 http://id.nlm.nih.gov/mesh/M0022497 http://id.nlm.nih.gov/mesh/M0003327 http://id.nlm.nih.gov/mesh/M0017693 http://id.nlm.nih.gov/mesh/M000604260 http://id.nlm.nih.gov/mesh/M0005491 http://id.nlm.nih.gov/mesh/M0001214 http://id.nlm.nih.gov/mesh/M0456188 http://id.nlm.nih.gov/mesh/M0020790 http://id.nlm.nih.gov/mesh/M0456185
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56640146 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID392622 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54767916 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7739 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID37542 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_660b428645036f443f55711551d54a3c http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45110509

Total number of triples: 55.